Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations.

Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations.

Fuente:Nutrients

Extracto: Cognitive-behavioral intervention seems to be the mainstay of treatment, while the role of medical agents, such as GLP-1 analogs and naltrexone/bupropion, has emerged.

Claves:binge eating, food cravings, food disorders, obesity, polycystic ovary syndrome

Cita:Nutrients 2024 Apr 3; 16 (7)

Autor/es:Stefanaki, Katerina (a)
Karagiannakis, Dimitrios S (b)

institución:(a) Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
(b) Academic Department of Gastroenterology, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071049

Hepatology consultation is associated with decreased early return to alcohol use after discharge from an inpatient alcohol use disorder treatment program.

Hepatology consultation is associated with decreased early return to alcohol use after discharge from an inpatient alcohol use disorder treatment program.

Fuente:Hepatology Communications

Extracto: Patients evaluated by hepatology had significantly lower rates of return to alcohol use and lower rates of hazardous drinking at 26 weeks but not at 52 weeks. These findings suggest that hepatology evaluation during inpatient treatment of AUD may lead to decreased rates of early return to alcohol use.

Cita:Hepatol Commun 2024 May 1; 8 (5)

Autor/es:Blaney, Hanna L (a)
Khalid, Mian B (b)

institución:(a) Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
(b) Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Conflicto:The authors have no conflicts to report.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1097/HC9.0000000000000414

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation.

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation.

Fuente:International Journal of Molecular Sciences

Extracto: Signaling via FIIa might be a presumed link between the coagulation system (tissue factor-FXa/FIIa-PAR1 axis), inflammation, and pro-fibrotic pathways (thrombo-inflammation) in FDAF.

Claves:MACE, PAR1, atrial fibrillation, atrial myopathy, protease-activated receptor 1, thrombin, thrombo-inflammation, tissue factor

Cita:Int J Mol Sci 2024 Apr 8; 25 (7)

Autor/es:Friebel, Julian (a)
Wegner, Max (b)

institución:(a) Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 12203 Berlin, Germany.
(b) DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/ijms25074109

Diet and Physical Activity in Fabry Disease

Diet and Physical Activity in Fabry Disease

Fuente:Nutrients

Tipo de trabajo:Revisión

Extracto: Therefore, the aim of this review is to summarize current knowledge on the role of nutrition and physical activity in FD patients.

Claves:FODMAPs, Fabry disease, inflammation, nutritional therapy, oxidative stress, physical activity

Cita:Nutrients 2024 Apr 4; 16 (7)

Autor/es:Muscogiuri, Giovanna (a)
De Marco, Oriana (b)

institución:(a) Unità di Endocrinologia, Dipartimento di Medicina Clinica e Chirurgia, Diabetologia ed Andrologia, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
(b) Endocrinology Unit, Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Department of Clinical Medicine and Surgery, University Medical School of Naples, Via Sergio Pansini 5, 80131 Naples, Italy.

Conflicto:Author Teodolinda Di Risi was employed by the Department of Public Health but collaborates on research with company CEINGE Biotecnologie Avanzate. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071061

Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging.

Fuente:Nutrients

Extracto: Furthermore, we aspire to explore bioactive compounds endowed with functional properties capable of modulating and restoring balance in this aging-related dysbiotic process through epigenetics alterations.

Claves:aging, dysbiosis, epigenetics, intestinal microbiota, polyphenols

Cita:Nutrients 2024 Apr 5; 16 (7)

Autor/es:Pereira, Quélita Cristina (a)
Fortunato, Isabela Monique (b)

institución:(a) Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University, Av. Sao Francisco de Assis, 218, Braganca Paulista 12916-900, SP, Brazil.
(b) Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University, Av. Sao Francisco de Assis, 218, Braganca Paulista 12916-900, SP, Brazil.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071066

No difference in postprandial mesenteric blood flow between healthy younger and elderly individuals.

No difference in postprandial mesenteric blood flow between healthy younger and elderly individuals.

Fuente:Scientific Reports

Extracto: This study provides tentative evidence that postprandial blood flow dynamics in SMA in healthy young and elderly subjects do not substantially differ, indicating that age is without impact on vascular response in SMA as an indicator for regulation of mesenteric perfusion in response to food intake.

Cita:Sci Rep 2024 Apr 15; 14 (1) : 8689.

Autor/es:Siebner, Thomas Hartwig (a)
Hove, Jens Dahlgaard (b)

institución:(a) Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark. thomas.hartwig.siebner@regionh.dk.
(b) Department of Cardiology, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark. thomas.hartwig.siebner@regionh.dk.

Conflicto:Hartwig R. Siebner has received honoraria as speaker from Sanofi Genzyme, Denmark and Novartis, Denmark, as consultant from Sanofi Genzyme, Denmark and as editor-in-chief (Neuroimage Clinical) and senior editor (NeuroImage) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany and from Gyldendal Publishers, Copenhagen, Denmark. Jens D. Hove has received honoraria... as speaker and consultant from Astra Zeneca, Denmark and Novo Nordisk, Denmark. Flemming Bendtsen has received honoraria as a consultant for Ferring Pharmaceuticals, Denmark. None of the competing interests listed above are directly related to this project. The other authors declare no competing interests.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41598-024-58111-w

The Effect of Fermentation on the Chemical Constituents of Gastrodia Tuber Hallimasch Powder (GTHP) Estimated by UHPLC-Q-Orbitrap HRMS and HPLC.

Fuente:Molecules (basel, Switzerland)

Extracto: The UHPLC-Q-Orbitrap HRMS and HPLC methods can effectively identify a variety of chemical components before and after the fermentation of GTHP. This study provides a valuable reference for further research on the rational clinical application and quality control improvement of GTHP.

Claves:GTHP, UHPLC-Q-Orbitrap HRMS, chemical composition, fermentation, fingerprinting

Cita:Molecules 2024 Apr 7; 29 (7)

Autor/es:Wu, Yaning (a)
Zhang, Hongwei (b)

institución:(a) School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
(b) School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.

Conflicto:Author Songbo Ma was employed by Luoyang Wokang Pharmaceutical Co., Ltd., Luoyang, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/molecules29071663

Deacetylated Konjac Glucomannan with a Slower Hydration Rate Delays Rice Digestion and Weakens Appetite Response.

Fuente:Molecules (basel, Switzerland)

Extracto: This study explored the nutritional effects of the hydration properties derived from the DKGM, which may contribute to modifying the high glycemic index food and provide ideas for the fabrication of food with enhanced satiating capacity.

Claves:appetite response, deacetylation, konjac glucomannan, simulated digestion

Cita:Molecules 2024 Apr 8; 29 (7)

Autor/es:Xu, Chenfeng (a)
Cheng, Kaixuan (b)

institución:(a) College of Biological and Food Engineering, Hubei Minzu University, Enshi 445002, China.
(b) Hubei Key Laboratory of Selenium Resource Research and Biological Application, Hubei Minzu University, Enshi 445002, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/molecules29071681

Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma.

Fuente:Technology in Cancer Research & Treatment

Extracto: Collectively, we established and verified an effective prognostic model that could separate cholangiocarcinoma patients into 2 heterogeneous cuproptosis subtypes based on the molecular or protein characteristics of 10 cuproptosis-related genes. These findings may provide potential benefits for unveiling molecular characteristics and defining subgroups could improve the early diagnosis and individualized treatment of cholangiocarcinoma patients.

Claves:cholangiocarcinoma, comprehensive analysis, cuproptosis, prognostic biomarker, tumor microenvironment

Cita:Technol Cancer Res Treat 2024 Jan-Dec; 23 : 15330338241239139.

Autor/es:Liu, Qiang (a)
Zhu, Jianpeng (b)

institución:(a) Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
(b) The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.

Conflicto:Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1177/15330338241239139

[Prehabilitation in chronic inflammatory bowel disease: the Proactive care pathway].

Fuente:Soins; la Revue de Reference Infirmiere

Extracto: Initial data are positive, showing an improvement in patients' physical capacity and quality of life after 6 weeks.

Claves:activité physique, inflammatory bowel disease, maladie inflammatoire chronique de l’intestin, nutrition, physical activity, sarcopenia, sarcopénie, therapeutic education, éducation thérapeutique

Cita:Soins 2024 Apr; 69 (884) : 29-32.

Autor/es:Lecoq, Émilie (a)
Alioui, Léa (b)

institución:(a) Service de gastroentérologie et assistance nutritive, Hôpital Beaujon, AP-HP, 100 boulevard du Général-Leclerc, 92110 Clichy, France.
(b) Service de gastroentérologie et assistance nutritive, Hôpital Beaujon, AP-HP, 100 boulevard du Général-Leclerc, 92110 Clichy, France.

Formato:Informe impreso

Idioma:fre

País de fuente:Francia

Sitio web:http://dx.doi.org/10.1016/j.soin.2024.02.007

Causes of obesity

Fuente:Clinical Medicine (london, England)

Tipo de trabajo:Revisión

Extracto: In this review, we discuss the impact of physical inactivity, excessive caloric intake, intrauterine environment, postnatal influences, insufficient sleep, drugs, medical conditions, socioeconomic status, ethnicity, psychosocial stress, endocrine disrupting chemicals and the gastrointestinal microbiome, on the occurrence of obesity.

Claves:causes, environment, epigenetics, genetics, modifiable, modifiable factors, obesity

Cita:Clin Med (Lond) 2023 Jul; 23 (4) : 284-291.

Autor/es:Masood, Beenish (a)
Moorthy, Myuri (b)

institución:(a) Barts Health NHS Trust, London, UK. Electronic address: beenish.masood@nhs.net.
(b) Barts NHS Health Trust, London, UK.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.7861/clinmed.2023-0168

Admission care bundles for decompensated cirrhosis are poorly utilised across the UK: results from a multi-centre retrospective study.

Fuente:Clinical Medicine (london, England)

Extracto: Thus, interdisciplinary work is required to develop tools which are widely used and improve care and outcomes for patients with decompensated cirrhosis.

Claves:care bundle, cirrhosis, equity, variation

Cita:Clin Med (Lond) 2023 May; 23 (3) : 193-200.

Autor/es:care bundle, cirrhosis, equity, variation

institución:care bundle, cirrhosis, equity, variation

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.7861/clinmed.2022-0541

Achieving Improving Quality in Liver Services (IQILS) accreditation - lessons learned from one unit's experience.

Fuente:Clinical Medicine (london, England)

Extracto: This article describes the approach that we took and the challenges that we met on the way to achieving accreditation.

Claves:IQILS, accreditation, liver services

Cita:Clin Med (Lond) 2023 May; 23 (3) : 213-218.

Autor/es:Kotha, Sreelakshmi (a)
Tritto, Giovanni (b)

institución:(a) Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: UK.sreelakshmi_kotha@yahoo.com.
(b) Guy's and St Thomas' NHS Foundation Trust, London, UK.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.7861/clinmed.2022-0452

Exploring the Link Between Ankylosing Spondylitis and Inflammatory Bowel Disease

Fuente:The Israel Medical Association Journal Imaj

Tipo de trabajo:Estudio de cohortes

Extracto: AS patients exhibit a markedly increased risk of developing IBD. These findings advocate for heightened clinical vigilance for IBD symptoms in AS patients and suggest the need for a multidisciplinary approach to patient care. Further research into the shared pathogenic pathways is needed to develop personalized treatment strategies and improve patient management.

Cita:Isr Med Assoc J 2024 Apr; 26 (4) : 226-231.

Autor/es:Sharif, Kassem (a)
Lahat, Adi (b)

institución:(a) Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
(b) Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Israel

Sitio web:

IL-33 Accelerates Chronic Atrophic Gastritis through AMPK-ULK1 Axis Mediated Autolysosomal Degradation of GKN1.

Fuente:International Journal of Biological Sciences

Extracto: Our findings unveil an IL-33-AMPK-ULK1 regulatory mechanism governing GKN1 protein stability in CAG, presenting potential therapeutic targets for its treatment.

Claves:AMPK, Autophagy, Chronic Atrophic Gastritis., GKN1, IL-33, ULK1

Cita:Int J Biol Sci 2024; 20 (6) : 2323-2338.

Autor/es:Liu, Kewei (a)
Huang, Hongxia (b)

institución:(a) Engineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences, Southwest University, Chongqing, 400715, China.
(b) Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.

Conflicto:Competing Interests: The authors have declared that no competing interest exists.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Australia

Sitio web:http://dx.doi.org/10.7150/ijbs.93573

Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge.

Fuente:Acta Oncologica (stockholm, Sweden)

Tipo de trabajo:Revisión

Extracto: Therefore case reporting remains important.

Cita:Acta Oncol 2024 Apr 15; 63 : 192-197.

Autor/es:Dirven, Iris (a)
Leclercq, Philippe (b)

institución:(a) Department of Gastro-enterology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. iris.dirven@uzbrussel.be.
(b) Department of Gastro-enterology, CHC MontLégia, Liège, Belgium.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suecia

Sitio web:http://dx.doi.org/10.2340/1651-226X.2023.35412

Intestinal obstruction as a result of intra-abdominal hematoma: a complication of low molecular weight heparin in pediatric patients.

Fuente:Cirugia Pediatrica Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica

Tipo de trabajo:Caso clínico

Extracto: DISCUSSION: The administration of subcutaneous heparin may cause intestinal wall hematomas due to its anticoagulating effect and to the risk of inadvertent punctures on small bowel loops.

Claves:Hematoma, Intestinal obstruction, Low molecular weight heparin (LMWH)

Cita:Cir Pediatr 2024 Apr 1; 37 (2) : 84-88.

Autor/es:Martínez Díaz, M (a)
Costa Roig, A (b)

institución:(a) Pediatric Surgery Department. Hospital Universitario y Politécnico La Fe. Valencia (Spain).
(b) Pediatric Surgery Department. Hospital Universitario y Politécnico La Fe. Valencia (Spain).

Formato:Informe virtual

Idioma:eng, spa

País de fuente:España

Sitio web:http://dx.doi.org/10.54847/cp.2024.02.18

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.

Fuente:Journal of Cellular and Molecular Medicine

Extracto: In order to provide basis for prevention and treatment of PCOS based on gut microbiota.

Claves:PCOS, gut microbiota, hormone, obesity

Cita:J Cell Mol Med 2024 Apr; 28 (8) : e18258.

Autor/es:Zhou, Min (a)
Yu, Jing (b)

institución:(a) Department of Gynaecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
(b) Department of Endocrinology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.

Conflicto:The authors have no relevant financial or non‐financial interests to disclose.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1111/jcmm.18258

Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020.

Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020.

Fuente:Jama Network Open

Extracto: AND RELEVANCE: In this cross-sectional study of phase 3 oncology trials, nearly half of trials presented a subgroup analysis in their primary publication. However, forest plots of these subgroup analyses largely lacked essential features for interpretation, and most differential treatment effect claims were not supported. Oncology subgroup analyses should be interpreted with caution, and improvements to the quality of subgroup analyses are needed.

Cita:JAMA Netw Open 2024 Mar 4; 7 (3) : e243379.

Autor/es:Sherry, Alexander D (a)
Hahn, Andrew W (b)

institución:(a) Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
(b) Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.

Conflicto:Conflict of Interest Disclosures: Dr Hahn reported receiving personal fees from Janssen, Medscape, Binaytara Foundation, Exelixis, and Intellisphere; travel support from Dava Oncology; and grants from Bayer and Eisai outside the submitted work. Dr McCaw reported being employed by Insitro. Dr Fuller reported receiving grants from the National Institutes of Health, National Science Foundation, and Elektra; personal fees from Elekta,... Siemens Medical Solutions, and Philips Medical Systems; travel support, speaking honoraria, and in-kind support from Elekta; and travel support and in-kind support from Philips Medical Systems outside the submitted work. Dr Meirson reported receiving personal fees from Purple Biotech outside the submitted work. Dr Msaouel reported receiving honoraria for service on a scientific advisory board for Mirati Therapeutics, Bristol Myers Squibb, and Exelixis; consulting for Axiom Healthcare Strategies; receiving support for nonbranded educational programs from DAVA Oncology, Exelixis, and Pfizer; serving as a medical steering committee member for the Kidney Cancer Association; serving as a kidney cancer scientific advisory board member for KCCure; and receiving research funding for clinical trials from Takeda, Bristol Myers Squibb, Mirati Therapeutics, Gateway for Cancer Research, and the University of Texas MD Anderson Cancer Center. No other disclosures were reported.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1001/jamanetworkopen.2024.3379

Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.

Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.

Fuente:Plos One

Tipo de trabajo:Estudio de cohortes

Extracto: Vaccination reduces the risk of severe COVID-19 in LT patients, regardless of the scheme used. Vaccination should be encouraged for all.

Cita:PLoS One 2024; 19 (3) : e0301198.

Autor/es:Azamar-Llamas, Daniel (a)
Arenas-Martinez, Josealberto Sebastiano (b)

institución:(a) Department of Gastroenterology and Liver Transplant Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
(b) Department of Gastroenterology and Liver Transplant Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1371/journal.pone.0301198